Overall, these data show that despite no overt change in TAZ/TEAD expression, SOX10-low, drug-tolerant cells exhibit up-regulation of YAP1/TAZ-TEAD signaling in melanoma, likely through multiple mechanisms including chromatin remodeling and c-Jun upregulation. This evidence concerns the gene YAP1 and melanoma.